Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[S,S]-reboxetine add-on versus placebo in postherpetic neuralgia on pregabalin
2005-005555-17Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of reboxetine in postherpetic neuralgia (PHN) (2 arms), sponsored by Pfizer. Primary endpoint: Change from baseline to Week 10 in weekly average pain score. Started Mar 2006; status: terminated.
02
Drugs
reboxetine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on 2005-005555-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005555-17.